Mapping inflammation onto mood: Inflammatory mediators of anhedonia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuroscience and Biobehavioral Reviews

• Publication date

  2016-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neubiorev.2016.02.017PMID 26915929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Neurobiology of Motivational Deficits in Depression--An Update on Candidate Pathomechanisms.

  2016cited by this paper
• Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder

  2015cited by this paper
• Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder

  2015cited by this paper
• Reply to: Serum zinc and the risk of depression in men: observations from a 20-year follow-up study.

  2015cited by this paper
• Structural and functional features of central nervous system lymphatics

  2015cited by this paper
• Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain

  2015cited by this paper
• Mesolimbic Dopamine and the Regulation of Motivated Behavior.

  2015cited by this paper
• Insulin resistance in brain alters dopamine turnover and causes behavioral disorders

  2015cited by this paper
• Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats

  2015cited by this paper
• Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.

  2015cited by this paper
• Neuroinflammation in Parkinson’s disease and its potential as therapeutic target

  2015cited by this paper
• Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression

  2015cited by this paper
• Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.

  2015cited by this paper
• Reward processing dysfunction in major depression, bipolar disorder and schizophrenia

  2015cited by this paper
• Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease.

  2015cited by this paper
• Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

  2015cited by this paper
• Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

  2014cited by this paper
• Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

  2014cited by this paper
• Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial.

  2014cited by this paper
• Liver-brain interactions in inflammatory liver diseases: implications for fatigue and mood disorders.

  2014cited by this paper
• Perforin Is a Novel Immune Regulator of Obesity-Related Insulin Resistance

  2014cited by this paper
• Anhedonia in substance use disorders: A systematic review of its nature, course and clinical correlates

  2014cited by this paper
• Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.

  2014cited by this paper
• Neuroinflammation Mediates Synergy between Cerebral Ischemia and Amyloid-β to Cause Synaptic Depression

  2014cited by this paper
• Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.

  2014cited by this paper
• Kynurenine and depressive symptoms in a poststroke population

  2014cited by this paper
• Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress

  2014cited by this paper
• Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.

  2014cited by this paper
• Integrated Neurobiology of Bipolar Disorder

  2014cited by this paper
• The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.

  2014cited by this paper
• Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials

  2014cited by this paper
• Inflamed moods: a review of the interactions between inflammation and mood disorders.

  2014cited by this paper
• Anhedonia in the age of RDoC.

  2014cited by this paper
• Dietary restriction reverses obesity-induced anhedonia.

  2014cited by this paper
• Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression.

  2013cited by this paper
• Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin.

  2013cited by this paper
• Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

  2013cited by this paper
• A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

  2013cited by this paper
• Dopamine Signaling in reward-related behaviors

  2013cited by this paper
• Neural response to emotional stimuli during experimental human endotoxemia

  2013cited by this paper
• Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.

  2013cited by this paper
• Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway.

  2013cited by this paper
• The vascular depression hypothesis: mechanisms linking vascular disease with depression

  2013cited by this paper
• Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration.

  2013cited by this paper
• Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression

  2013cited by this paper
• Omega-3 polyunsaturated fatty acids for major depressive disorder

  2013cited by this paper
• Trait anhedonia is associated with reduced reactivity and connectivity of mesolimbic and paralimbic reward pathways.

  2013cited by this paper
• Zinc in depression: a meta-analysis.

  2013cited by this paper
• Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke.

  2013cited by this paper
• An examination of anhedonia separate from depression in Alzheimer's disease: a preliminary study.

  2013cited by this paper
• Interleukin-17 in post-stroke neurodegeneration.

  2013cited by this paper
• Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.

  2013cited by this paper
• The brain reward circuitry in mood disorders

  2013cited by this paper
• Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates

  2013cited by this paper
• Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies.

  2013cited by this paper
• The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

  2013cited by this paper
• Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies.

  2013cited by this paper
• Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo

  2013cited by this paper
• Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry

  2013cited by this paper
• Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

  2013cited by this paper
• Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.

  2013cited by this paper
• Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

  2013cited by this paper
• Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

  2013cited by this paper
• Is there a role for curcumin in the treatment of bipolar disorder?

  2013cited by this paper
• Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates

  2012cited by this paper
• Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

  2012cited by this paper
• Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression.

  2012cited by this paper
• The Temporal Experience of Pleasure Scale (TEPS): Exploration and Confirmation of Factor Structure in a Healthy Chinese Sample

  2012cited by this paper
• Novel therapeutic targets in depression: minocycline as a candidate treatment.

  2012cited by this paper
• Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.

  2012cited by this paper
• Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia?

  2012cited by this paper
• Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.

  2012cited by this paper
• Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

  2012cited by this paper
• Stress‐induced anhedonia is associated with an increase in Alzheimer's disease‐related markers

  2012cited by this paper
• Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level

  2012cited by this paper
• Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression.

  2012cited by this paper
• Post-Stroke Depression: Main Phenomenological Clusters and their Relationships with Clinical Measures

  2012cited by this paper
• Association of vascular factors with apathy in community-dwelling elderly individuals.

  2012cited by this paper
• L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

  2012cited by this paper
• Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects

  2012cited by this paper
• Re‐evaluating the role of the orbitofrontal cortex in reward and reinforcement

  2012cited by this paper
• Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.

  2012cited by this paper
• Anhedonia in Parkinson's disease: an overview.

  2012cited by this paper
• Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge.

  2012cited by this paper
• Glucose Metabolism in the Insula and Cingulate Is Affected by Systemic Inflammation in Humans

  2012cited by this paper
• The possible role of the kynurenine pathway in anhedonia in adolescents

  2012cited by this paper
• Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.

  2012cited by this paper
• P3‐397: Increase in cerebrovascular resistance and reduction in cerebral blood flow in patients with mild cognitive impairment

  2012cited by this paper
• Anhedonia Is an Important Factor of Health-Related Quality-of-Life Deficit in Schizophrenia and Schizoaffective Disorder

  2011cited by this paper
• New from NPG: Genome-wide association study identifies five new schizophrenia loci

  2011cited by this paper
• Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease.

  2011cited by this paper
• Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

  2011cited by this paper
• Alpha7 Nicotinic Acetylcholine Receptors Modulate Motivation to Self-Administer Nicotine: Implications for Smoking and Schizophrenia

  2011cited by this paper
• B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

  2011cited by this paper
• Markers of gluten sensitivity and celiac disease in bipolar disorder.

  2011cited by this paper
• Impaired CNS leptin action is implicated in depression associated with obesity.

  2011cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• Obesity/hyperleptinemic phenotype adversely affects hippocampal plasticity: effects of dietary restriction.

  2011cited by this paper
• Reconsidering anhedonia in depression: lessons from translational neuroscience.

  2011cited by this paper
• Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms.

  2011cited by this paper

• Synaptic effects of interleukin-6 on human iPSC-derived dopaminergic neurons.

  2026cites this paper
• Recent Change in Anhedonia, Major Depression and Low-Grade Inflammation: Dangerous Liaisons? A Study Based on a Cohort Referred for Polysomnography

  2025cites this paper
• Factors of hedonistic balance in the post-infection period of COVID-19 in psychiatric inpatients

  2025cites this paper
• Associations between prenatal inflammation and dimensions of depressive symptoms across the perinatal period.

  2025influential citation
• Effects of glutamatergic modulators on striatal activation, functional connectivity and reward in persons with major depressive disorder and healthy controls: A systematic review of fMRI studies.

  2025cites this paper
• Acute systemic immune challenge induces cognitive impairments and anhedonia through interferon-induced transmembrane protein 3 in adult male mice.

  2025cites this paper
• Greater fatigue is more strongly associated with reduced reward sensitivity in the long-term phase of coronavirus disease (COVID-19) than in the early phase

  2025cites this paper
• Neuroinflammation in the Pathogenesis of Psychiatric Disorder

  2025cites this paper
• Regular consumption of fruits, vegetables, and whole grain foods is associated with fewer depressive symptoms in older adults: a cross-sectional analysis of EpiFloripa Aging cohort study, Brazil

  2025cites this paper
• Linking sense of purpose and multiple markers of health in older adulthood: A bidirectional approach

  2025cites this paper
• Anti-inflammatory interventions for the treatment and prevention of depression among older adults: a systematic review and meta-analysis

  2025cites this paper
• The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder

  2025cites this paper
• Prevalence of anhedonia in women with deep endometriosis

  2025cites this paper
• Weighing the predictive role of neural factors for adolescent anhedonia in the presence of demographic and clinical factors

  2025cites this paper
• A randomized proof-of-mechanism trial of TNF antagonism for motivational anhedonia and related corticostriatal circuitry in depressed patients with high inflammation

  2024cites this paper
• Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.

  2024cites this paper
• A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation

  2024cites this paper
• The potential inflammatory biomarker of bipolar disorder: Neutrophil-to-lymphocyte Ratio – A hospital-based cross-sectional study

  2024cites this paper
• Association of anhedonia with brain-derived neurotrophic factor and interleukin-10 in major depressive disorder.

  2024cites this paper
• Neural Cell-types and Circuits Linking Thermoregulation and Social Behavior.

  2024cites this paper
• [Possibilities of «therapeutic retargeting» of 3-hydroxypyridine and succinic acid derivatives due to their dopaminergic action].

  2024cites this paper
• Annual Research Review: Puberty and the development of anhedonia - considering childhood adversity and inflammation.

  2024cites this paper
• Fatigue during acute systemic inflammation is associated with reduced mental effort expenditure while task accuracy is preserved

  2023cites this paper
• Involvement of the Receptor for Advanced Glycation End Products (RAGE) in High Fat-High Sugar Diet-Induced Anhedonia in Rats.

  2023cites this paper
• Peripheral blood infl ammatory markers as signals of mental disorders in a sample of elderly people

  2023cites this paper
• Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign.

  2023cites this paper
• Peripheral Inflammatory Markers in Subtypes and Core Features of Depression: A Systematized Review

  2023cites this paper
• Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications.

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Cannabinoid receptor 2 evolutionary gene loss makes parrots more susceptible to neuroinflammation

  2022cites this paper
• Validation of a novel method of ultraviolet-induced cutaneous inflammation and its associations with anhedonia

  2022cites this paper
• Association of the plasma complement system with brain volume deficits in bipolar and major depressive disorders

  2022cites this paper
• Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits

  2022cites this paper
• Brain Structural and Functional Alterations in Multiple Sclerosis-Related Fatigue: A Systematic Review

  2022cites this paper
• Greater Cumulative Lifetime Stressor Exposure Predicts a Blunted RewP in Adolescent Girls Over Two Years.

  2022cites this paper
• Younger women are more susceptible to inflammation: A longitudinal examination of the role of aging in inflammation and depressive symptoms.

  2022cites this paper
• Myricitrin exhibits antidepressant-like effects and reduces IL-6 hippocampal levels in the chronic mild stress model.

  2022cites this paper
• Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta‐analysis

  2022cites this paper
• Treatment-Resistant Depression with Anhedonia: Integrating Clinical and Preclinical Approaches to Investigate Distinct Phenotypes.

  2022cites this paper
• Co-occurrence of Fatigue and Depression in People With Multiple Sclerosis: A Mini-Review

  2022cites this paper
• VITAMIN D AND DEPRESSION IN OLDER ADULTS: LESSONS LEARNED FROM OBSERVATIONAL AND CLINICAL STUDIES.

  2022cites this paper
• Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression

  2021cites this paper
• Aging as a Context for the Role of Inflammation in Depressive Symptoms

  2021cites this paper
• Mechanisms and Methods to Understand Depressive Symptoms

  2021cites this paper
• Immunity as a Common Risk Pathway for Psychiatric and Medical Comorbidity

  2021cites this paper
• Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers.

  2021cites this paper
• A chicken and egg scenario in psychoneuroimmunology: Bidirectional mechanisms linking cytokines and depression

  2021cites this paper
• Elevated C-reactive protein levels across diagnoses: The first comparison among inpatients with major depressive disorder, bipolar disorder, or obsessive-compulsive disorder.

  2021cites this paper
• From childhood maltreatment to adult inflammation: Evidence for the mediational status of social anxiety and low positive affect

  2021cites this paper
• Pathophysiology linking depression and type 2 diabetes: Psychotherapy, physical exercise, and fecal microbiome transplantation as damage control

  2021cites this paper
• Sex differences in circulating inflammatory mediators as a function of substance use disorder.

  2021cites this paper
• Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes.

  2020cites this paper
• Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation

  2020cites this paper
• Post-trauma anhedonia is associated with increased substance use in a recently-traumatized population.

  2020cites this paper
• Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia.

  2020cites this paper
• Efficacy of Adjunctive Infliximab vs. Placebo in the Treatment of Anhedonia in Bipolar I/II Depression.

  2020cites this paper
• Characterizing anhedonia: A systematic review of neuroimaging across the subtypes of reward processing deficits in depression

  2020cites this paper
• Anhedonia and increased evoked immune response

  2020cites this paper
• The relationship between demoralization and depressive symptoms among patients from the general hospital: network and exploratory graph analysis.

  2020cites this paper
• Correlates of C-reactive protein with neural reward circuitry in adolescents with psychiatric symptoms

  2020cites this paper
• Neuromodulatory effect of curcumin on catecholamine systems and inflammatory cytokines in ovariectomized female rats

  2020cites this paper
• THE PRESENCE OF PERIPHERAL INFLAMMATORY MARKERS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER, THE ASSOCIATED SYMPTOMS PROFILES AND THE ANTIDEPRESSANT EFFICACY OF CELECOXIB

  2020cites this paper
• Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms

  2020cites this paper
• Using Precision Medicine with a Neurodevelopmental Perspective to Study Inflammation and Depression

  2020cites this paper
• Severe anhedonia among adolescents with bipolar disorder is common and associated with increased psychiatric symptom burden.

  2020cites this paper
• Brain Structure and Subclinical Symptoms: A Dimensional Perspective of Psychopathology in the Depression and Anxiety Spectrum

  2019cites this paper
• Population Studies of the Heritable Influences on the Mind and Brain

  2019cites this paper
• Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial

  2019cites this paper
• Candidate Biomarkers of Suicide Crisis Syndrome: What to Test Next? A Concept Paper

  2019cites this paper
• Gene Regulatory Network of Dorsolateral Prefrontal Cortex: a Master Regulator Analysis of Major Psychiatric Disorders

  2019cites this paper
• Vitamin D and Depression in Women: A Mini-review

  2019cites this paper
• Vitamin D3 Modulates NF-kB/p65, 17β-Estradiol, and Vitamin D Receptors Expression at Estrogen Deficiency

  2019cites this paper
• Retrospectively reported childhood physical abuse, systemic inflammation, and resting corticolimbic connectivity in midlife adults.

  2019cites this paper
• An Integrative and Mechanistic Model of Impaired Belief Updating in Schizophrenia

  2019cites this paper
• Factor analyses differentiate clinical phenotypes of idiopathic and interferon-alpha-induced depression.

  2019cites this paper
• Role of inflammation in depression relapse

  2019cites this paper
• A clinical model for identifying an inflammatory phenotype in mood disorders.

  2019cites this paper
• Relationships between neural activation during a reward task and peripheral cytokine levels in youth with diverse psychiatric symptoms.

  2019cites this paper
• Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health

  2019cites this paper
• Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D

  2019cites this paper
• Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways

  2019cites this paper
• Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review

  2019cites this paper
• Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse

  2019cites this paper
• Eating for Happiness – New Mechanisms for the Role of Nutrition in the Prevention of Depression

  2019cites this paper
• ASSOCIATIONS BETWEEN RETROSPECTIVE REPORTS OF ADVERSE CHILDHOOD EXPERIENCES, SYSTEMIC INFLAMMATION, AND RESTING BRAIN CONNECTIVITY IN MIDLIFE ADULTS

  2018cites this paper
• Depression in people with type 2 diabetes: current perspectives

  2018cites this paper
• The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive 
Illness in the Elderly

  2018cites this paper
• The two sides of the coin of psychosocial stress: evaluation by positron emission tomography

  2018cites this paper
• Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation

  2018cites this paper
• Genome-wide Analysis of Insomnia (N=1,331,010) Identifies Novel Loci and Functional Pathways

  2018cites this paper
• Association of T and non-T cell cytokines with anhedonia: Role of gender differences.

  2018cites this paper
• L’anhédonie dans la dépression unipolaire : de son évaluation à sa prise en charge

  2018cites this paper
• Peripheral TNFα elevations in abstinent alcoholics are associated with hepatitis C infection

  2018cites this paper
• Antidepressant and Antipsychotic-like Activity of the Ethanolic Extract of the Leaves of Maytenus macrocarpa

  2018cites this paper
• Depressive disorders: Processes leading to neurogeneration and potential novel treatments.

  2018cites this paper
• ASSOCIATION BETWEEN THE MAGNITUDE OF THE IMMUNE RESPONSE AND RECURRENT MAJOR DEPRESSION DISORDER IN HUMANS AND DEPRESSION-LIKE BEHAVIOR IN ANIMALS

  2018cites this paper
• Biomarkers of Depression: Potential Diagnostic Tools

  2018cites this paper
• The role of inflammation in core features of depression: Insights from paradigms using exogenously‐induced inflammation

  2018cites this paper
• Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions.

  2017cites this paper
• Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans

  2017cites this paper